| Style | Citing Format |
|---|---|
| MLA | Ms Ansari Mahshid SADAT, et al.. "Use of the Oral Janus Kinase Inhibitor Tofacitinib in the Treatment of Morphea: A Retrospective Study." Journal of the American Academy of Dermatology, vol. 93, no. 3, 2025, pp. 769-771. |
| APA | Ms Ansari Mahshid SADAT, Sm Vahabi Seyed MOHAMMAD, H Memari HURIA, Fs Hosseini Fatemeh SADAT, S Bahramian SAEED, I Etesami IFA (2025). Use of the Oral Janus Kinase Inhibitor Tofacitinib in the Treatment of Morphea: A Retrospective Study. Journal of the American Academy of Dermatology, 93(3), 769-771. |
| Chicago | Ms Ansari Mahshid SADAT, Sm Vahabi Seyed MOHAMMAD, H Memari HURIA, Fs Hosseini Fatemeh SADAT, S Bahramian SAEED, I Etesami IFA. "Use of the Oral Janus Kinase Inhibitor Tofacitinib in the Treatment of Morphea: A Retrospective Study." Journal of the American Academy of Dermatology 93, no. 3 (2025): 769-771. |
| Harvard | Ms Ansari Mahshid SADAT et al. (2025) 'Use of the Oral Janus Kinase Inhibitor Tofacitinib in the Treatment of Morphea: A Retrospective Study', Journal of the American Academy of Dermatology, 93(3), pp. 769-771. |
| Vancouver | Ms Ansari Mahshid SADAT, Sm Vahabi Seyed MOHAMMAD, H Memari HURIA, Fs Hosseini Fatemeh SADAT, S Bahramian SAEED, I Etesami IFA. Use of the Oral Janus Kinase Inhibitor Tofacitinib in the Treatment of Morphea: A Retrospective Study. Journal of the American Academy of Dermatology. 2025;93(3):769-771. |
| BibTex | @article{ author = {Ms Ansari Mahshid SADAT and Sm Vahabi Seyed MOHAMMAD and H Memari HURIA and Fs Hosseini Fatemeh SADAT and S Bahramian SAEED and I Etesami IFA}, title = {Use of the Oral Janus Kinase Inhibitor Tofacitinib in the Treatment of Morphea: A Retrospective Study}, journal = {Journal of the American Academy of Dermatology}, volume = {93}, number = {3}, pages = {769-771}, year = {2025} } |
| RIS | TY - JOUR AU - Ms Ansari Mahshid SADAT AU - Sm Vahabi Seyed MOHAMMAD AU - H Memari HURIA AU - Fs Hosseini Fatemeh SADAT AU - S Bahramian SAEED AU - I Etesami IFA TI - Use of the Oral Janus Kinase Inhibitor Tofacitinib in the Treatment of Morphea: A Retrospective Study JO - Journal of the American Academy of Dermatology VL - 93 IS - 3 SP - 769 EP - 771 PY - 2025 ER - |